Literature DB >> 11764087

Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures.

M Takao1, B Ghetti, J R Murrell, F W Unverzagt, G Giaccone, F Tagliavini, O Bugiani, P Piccardo, C M Hulette, B J Crain, M R Farlow, A Heyman.   

Abstract

We report clinical, neuropathologic and molecular genetic data from an individual affected by a familial Alzheimer disease (AD) variant. The proband had an onset of dementia at age 29 followed by generalized seizures a year later. He died at age 40. Neuropathologically, he had severe brain atrophy and characteristic histopathologic lesions of AD. Three additional neuropathologic features need to be emphasized: 1) severe deposition of Abeta in the form of diffuse deposits in the cerebral and cerebellar cortices, 2) numerous Abeta deposits in the subcortical white matter and in the centrum semiovale, and 3) numerous ectopic neurons, often containing tau-immunopositive neurofibrillary tangles, in the white maner of the frontal and temporal lobes. A molecular genetic analysis of DNA extracted from brain tissue of the proband revealed a S169L mutation in the Presenilin 1 (PSEN1) gene. The importance of this case lies in the presence of ectopic neurons in the white matter, early-onset seizures, and a PSEN1 mutation. We hypothesize that the PSEN1 mutation may have a causal relationship with an abnormality in neuronal development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11764087     DOI: 10.1093/jnen/60.12.1137

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  14 in total

1.  White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.

Authors:  Seonjoo Lee; Fawad Viqar; Molly E Zimmerman; Atul Narkhede; Giuseppe Tosto; Tammie L S Benzinger; Daniel S Marcus; Anne M Fagan; Alison Goate; Nick C Fox; Nigel J Cairns; David M Holtzman; Virginia Buckles; Bernardino Ghetti; Eric McDade; Ralph N Martins; Andrew J Saykin; Colin L Masters; John M Ringman; Natalie S Ryan; Stefan Förster; Christoph Laske; Peter R Schofield; Reisa A Sperling; Stephen Salloway; Stephen Correia; Clifford Jack; Michael Weiner; Randall J Bateman; John C Morris; Richard Mayeux; Adam M Brickman
Journal:  Ann Neurol       Date:  2016-04-27       Impact factor: 10.422

2.  Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.

Authors:  John M Ringman; Giovanni Coppola; David Elashoff; Yaneth Rodriguez-Agudelo; Luis D Medina; Karen Gylys; Jeffrey L Cummings; Greg M Cole
Journal:  Dement Geriatr Cogn Disord       Date:  2012-02-13       Impact factor: 2.959

Review 3.  Alzheimer's secretases regulate voltage-gated sodium channels.

Authors:  Dora M Kovacs; Manuel T Gersbacher; Doo Yeon Kim
Journal:  Neurosci Lett       Date:  2010-09-15       Impact factor: 3.046

4.  Antisense reduction of tau in adult mice protects against seizures.

Authors:  Sarah L DeVos; Dustin K Goncharoff; Guo Chen; Carey S Kebodeaux; Kaoru Yamada; Floy R Stewart; Dorothy R Schuler; Susan E Maloney; David F Wozniak; Frank Rigo; C Frank Bennett; John R Cirrito; David M Holtzman; Timothy M Miller
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

5.  Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

Authors:  Alex E Roher; Chera L Maarouf; Michael Malek-Ahmadi; Jeffrey Wilson; Tyler A Kokjohn; Ian D Daugs; Charisse M Whiteside; Walter M Kalback; Mimi P Macias; Sandra A Jacobson; Marwan N Sabbagh; Bernardino Ghetti; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 6.  Chasing genes in Alzheimer's and Parkinson's disease.

Authors:  Aida M Bertoli-Avella; Ben A Oostra; Peter Heutink
Journal:  Hum Genet       Date:  2004-03-04       Impact factor: 4.132

7.  Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's disease.

Authors:  Gregory D Van Vickle; Chera L Esh; Tyler A Kokjohn; R Lyle Patton; Walter M Kalback; Dean C Luehrs; Thomas G Beach; Amanda J Newel; Francisco Lopera; Bernardino Ghetti; Ruben Vidal; Eduardo M Castaño; Alex E Roher
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

8.  Mutant presenilin 1 increases the expression and activity of BACE1.

Authors:  Luca Giliberto; Roberta Borghi; Alessandra Piccini; Rosa Mangerini; Sandro Sorbi; Gabriella Cirmena; Anna Garuti; Bernardino Ghetti; Fabrizio Tagliavini; Mohamed R Mughal; Mark P Mattson; Xiongwei Zhu; Xinglong Wang; Michela Guglielmotto; Elena Tamagno; Massimo Tabaton
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

Review 9.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

10.  Seizures as an early symptom of autosomal dominant Alzheimer's disease.

Authors:  Jonathan Vöglein; Soheyl Noachtar; Eric McDade; Kimberly A Quaid; Stephen Salloway; Bernardino Ghetti; James Noble; Sarah Berman; Jasmeer Chhatwal; Hiroshi Mori; Nick Fox; Ricardo Allegri; Colin L Masters; Virginia Buckles; John M Ringman; Martin Rossor; Peter R Schofield; Reisa Sperling; Mathias Jucker; Christoph Laske; Katrina Paumier; John C Morris; Randall J Bateman; Johannes Levin; Adrian Danek
Journal:  Neurobiol Aging       Date:  2018-12-05       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.